Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle.
Bhoori
Sherrie
S
Liver Unit, Hepato-Oncology Group and Molecular Pathology, National Cancer Institute, Fondazione Istituto Nazionale Tumori, Milan, Italy.
Toffanin
Sara
S
Sposito
Carlo
C
Germini
Alessandro
A
Pellegrinelli
Alessandro
A
Lampis
Andrea
A
Mazzaferro
Vincenzo
V